View by Year:
Select Year View All 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Zhang S, Long H, Yang YL, Wang Y, Hsieh D, Li W, Au A, Stoppler HJ, Xu Z, Jablons DM, You L
Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells.
Journal of cellular and molecular medicine , Jul-2013;17(7):854-62. Epub 2013 May 8.
Kratz JR, Tham PT, Mulvihill MS, Ziaei F, Ray MR, Hurst JW, Segal MR, Berryman DM, Chu W, He B, Jablons DM, Mann MJ
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B , Jun-2013;22(2):65-9.
Mulvihill MS, Kratz JR, Pham P, Jablons DM, He B
The role of stem cells in airway repair: implications for the origins of lung cancer.
Chinese journal of cancer , Feb-2013;32(2):71-4. Epub 2012 Nov 1.
Zhang Y, He J, Zhang F, Li H, Yue D, Wang C, Jablons DM, He B, Lui N
SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.
Journal of experimental & clinical cancer research : CR , 2013;[epublish]32:7.
Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons DM, He B
Gli as a novel therapeutic target in malignant pleural mesothelioma.
PloS one , 2013;8(3):e57346.
Kim IJ, Quigley D, To MD, Pham P, Lin K, Jo B, Jen KY, Raz D, Kim J, Mao JH, Jablons D, Balmain A
Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas.
Nature communications , 2013;4:1701.
Mo ML, Chen Z, Zhou HM, Li H, Hirata T, Jablons DM, He B
Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer.
Journal of experimental & clinical cancer research : CR , 2013;[epublish]32:29.
Tsao MS, Jablons DM
Molecular prognostication of non-small cell lung cancer.
Seminars in thoracic and cardiovascular surgery , 2013;25(1):4-7.
Bravo DT, Yang YL, Kuchenbecker K, Hung MS, Xu Z, Jablons DM, You L
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer.
BMC cancer , 2013;[epublish]13:316.
Liu S, Hsieh D, Yang YL, Xu Z, Peto C, Jablons DM, You L
Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
BMC pharmacology & toxicology , 2013;[epublish]14:36.
Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, Li H, Zhou HM, Jablons DM, He B
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
PloS one , 2013;[epublish]8(8):e71816.
Kratz JR, Van den Eeden SK, He J, Jablons DM, Mann MJ
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
JAMA , Oct-24-2012;308(16):1629-31.
Kim JW, Lee S, Lui N, Choi H, Mulvihill M, Fang LT, Kang HC, Kwon YW, Jablons D, Kim IJ
A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
Oncology reports , Oct-2012;28(4):1225-30. Epub 2012 Jul 26.
Li T, Hou SC, Mao JH, Wang YC, Lu XD, Tan JL, You B, Liu YP, Ni J, Au A, Jablons DM, Xu Z, You L
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma.
Journal of clinical pathology , Sep-2012;65(9):855-8. Epub 2012 May 8.
Choi H, Kratz J, Pham P, Lee S, Ray R, Kwon YW, Mao JH, Kang HC, Jablons D, Kim IJ
Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
International journal of oncology , Jun-2012;40(6):1900-6. Epub 2012 Mar 07.
